Lucid Diagnostics Inc. Annual Selling and Marketing Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Lucid Diagnostics Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2020 to 2023.
  • Lucid Diagnostics Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $4.21M, a 4.42% increase year-over-year.
  • Lucid Diagnostics Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $16.6M, a 2.65% decline year-over-year.
  • Lucid Diagnostics Inc. annual Selling and Marketing Expense for 2023 was $16.4M, a 1.67% increase from 2022.
  • Lucid Diagnostics Inc. annual Selling and Marketing Expense for 2022 was $16.1M, a 207% increase from 2021.
  • Lucid Diagnostics Inc. annual Selling and Marketing Expense for 2021 was $5.26M, a 303% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.4M +$270K +1.67% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 $16.1M +$10.9M +207% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $5.26M +$3.96M +303% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $1.31M Jan 1, 2020 Dec 31, 2020 10-K 2022-04-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.